ED
KRYS icon

Exane Derivatives’s Krystal Biotech KRYS Stock Holding History

Exane Derivatives’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,016
Closed -$87.2K – 698
2020
Q1 		$87.2K Buy
+2,016
New +$87.2K 0.02% 280